Introduction:
DYTEL is a comprehensive range of antihypertensive medications based on Telmisartan, a long-acting angiotensin II receptor blocker (ARB). Designed for the effective management of hypertension and cardiovascular risk, the DYTEL range includes monotherapy options as well as fixed-dose combinations with Hydrochlorothiazide, Amlodipine, Chlorthalidone, Cilnidipine, and Metoprolol.
Formulated for 24-hour blood pressure control, DYTEL is ideal for use in patients with uncontrolled hypertension, diabetes, chronic kidney disease, and post-cardiovascular event management. All variants are available in ALU-ALU or Aluminium Foil blister packs (10 x 10 tablets) for maximum stability and shelf life.
Product Range & Benefits:
1. DYTEL-20
Composition: Telmisartan 20 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: Mild hypertension or initial therapy in sensitive patients.
Key Benefits:
-
Blocks angiotensin II, reducing vasoconstriction and aldosterone release
-
Well-tolerated starter dose
-
Effective for early-stage hypertension
2. DYTEL-40
Composition: Telmisartan 40 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: Monotherapy for moderate hypertension and cardiovascular risk reduction.
Key Benefits:
-
Sustained 24-hour BP control
-
Protective against stroke and heart attack
-
Excellent safety profile
3. DYTEL-40 H
Composition: Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: Combination therapy for better volume and BP control.
Key Benefits:
-
Diuretic synergy for enhanced BP lowering
-
Reduces fluid overload
-
Ideal for salt-sensitive patients
4. DYTEL-80
Composition: Telmisartan 80 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: High-dose monotherapy for difficult-to-control hypertension.
Key Benefits:
-
Maximum antihypertensive effect of Telmisartan
-
Improves arterial compliance
-
Once-daily dosing
5. DYTEL-80 H
Composition: Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: For resistant hypertension needing intensified treatment.
Key Benefits:
-
Powerful dual mechanism
-
Superior BP reduction
-
Prevents morning BP surge
6. DYTEL-A
Composition: Telmisartan 40 mg + Amlodipine 5 mg
Packaging: ALUMINIUM FOIL, 10 x 10 Tablets
Use: Dual therapy for patients unresponsive to ARB monotherapy.
Key Benefits:
-
Combines ARB and calcium channel blocker
-
Smooth BP control without reflex tachycardia
-
Improves patient adherence
7. DYTEL-AC
Composition: Telmisartan 40 mg + Chlorthalidone 12.5 mg + Amlodipine 5 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: Triple-drug regimen for severely uncontrolled BP.
Key Benefits:
-
Synergistic triple action
-
Reduces CV events in high-risk patients
-
Simplifies polypharmacy
8. DYTEL-AMH
Composition: Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg + Amlodipine 5 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: For patients requiring RAAS blockade, volume reduction, and vasodilation.
Key Benefits:
-
Broad-spectrum BP control
-
Combats fluid retention and vascular stiffness
-
Ideal for diabetics and elderly patients
9. DYTEL-C
Composition: Telmisartan 40 mg + Cilnidipine 10 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: Effective for hypertension with proteinuria or sympathetic overactivity.
Key Benefits:
-
Cilnidipine blocks both L- and N-type calcium channels
-
Reduces proteinuria
-
Minimizes heart rate fluctuations
10. DYTEL-CT 12.5
Composition: Telmisartan 40 mg + Chlorthalidone 12.5 mg
Packaging: ALUMINIUM FOIL, 10 x 10 Tablets
Use: Alternative diuretic combo for volume-sensitive hypertension.
Key Benefits:
-
Long-acting diuretic
-
Sustained 24-hour control
-
Improves arterial stiffness
11. DYTEL-MT 50
Composition: Telmisartan 40 mg + Metoprolol (ER) 50 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: Hypertension with tachycardia, angina, or post-MI management.
Key Benefits:
-
Beta-blocker + ARB for post-MI support
-
Controls heart rate and BP
-
Cardio-protective profile
12. DYTEL-TRIO 12.5
Composition: Telmisartan 40 mg + Chlorthalidone 12.5 mg + Cilnidipine 10 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: Advanced triple combination for complex hypertension.
Key Benefits:
-
Combines RAAS inhibition, vasodilation, and diuresis
-
Suitable for high-risk cardiovascular patients
-
Simplifies multi-drug regimens
Indications:
-
Essential and secondary hypertension
-
Resistant or high-risk hypertension
-
Diabetic nephropathy and CKD
-
Post-stroke and post-MI management
-
Cardiovascular risk reduction
Dosage and Administration:
-
Monotherapy: One tablet once daily
-
Combinations: One tablet once daily, preferably with food
-
Adjust as per clinical response and physician guidance
-
Regular monitoring of BP, renal function, and electrolytes is recommended
Precautions & Warnings:
-
Avoid during pregnancy and breastfeeding
-
Caution in patients with renal artery stenosis or hepatic impairment
-
Monitor serum potassium, especially with diuretics
-
Not recommended with ACE inhibitors in certain conditions
-
Dose adjustment may be necessary in elderly or volume-depleted patients
Possible Side Effects:
-
Dizziness, fatigue, or headache
-
Elevated potassium levels (hyperkalemia)
-
Mild gastrointestinal upset
-
Rare renal function changes
-
Swelling or flushing (Amlodipine combinations)
Conclusion:
The DYTEL range provides a clinically versatile and evidence-backed solution for managing hypertension across diverse patient profiles. Whether as monotherapy or as part of a dual/triple drug regimen, DYTEL ensures comprehensive blood pressure control, organ protection, and cardiovascular safety.
For reliable, long-term hypertension therapy, trust DYTEL – the complete Telmisartan-based solution for modern cardiovascular care.
Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category Cardiac
You can also contact us https://diabetes-cardiac.com/contact-us/
